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The finding that reelin expression is significantly decreased in mood and psychotic
disorders, together with evidence that reelin can regulate key aspects of hippocampal
plasticity in the adult brain, brought our research group and others to study the
possible role of reelin in the pathogenesis of depression. This review describes recent
progress on this topic using an animal model of depression that makes use of repeated
corticosterone (CORT) injections. This methodology produces depression-like symptoms
in both rats and mice that are reversed by antidepressant treatment. We have reported
that CORT causes a decrease in the number of reelin-immunopositive cells in the
dentate gyrus subgranular zone (SGZ), where adult hippocampal neurogenesis takes
place; that down-regulation of the number of reelin-positive cells closely parallels
the development of a depression-like phenotype during repeated CORT treatment;
that reelin downregulation alters the co-expression of reelin with neuronal nitric oxide
synthase (nNOS); that deficits in reelin might also create imbalances in glutamatergic
and GABAergic circuits within the hippocampus and other limbic structures; and
that co-treatment with antidepressant drugs prevents both reelin deficits and the
development of a depression-like phenotype. We also observed alterations in the
pattern of membrane protein clustering in peripheral lymphocytes in animals with low
levels of reelin. Importantly, we found parallel changes in membrane protein clustering
in depression patients, which differentiated two subpopulations of naïve depression
patients that showed a different therapeutic response to antidepressant treatment. Here,
we review these findings and develop the hypothesis that restoring reelin-related function
could represent a novel approach for antidepressant therapies.
Keywords: reelin, depression, hippocampus, neurogenesis, neural plasticity, lymphocytes, membrane protein
clustering
BRIEF HISTORY OF REELIN IN THE NERVOUS SYSTEM
The reeler mouse has been widely studied since the 1950’s as a model to understand neural
development and developmental dysregulations (reviewed in Lambert de Rouvroit and Goffinet,
1998). However, when the reelin gene was cloned by D’Arcangelo et al. (1995), a new field
focused on the neurobiology of reelin was firmly established. Early on, reelin was primarily thought
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of as a developmental molecule highly expressed in cortical
and hippocampal Cajal-Retzius cells and cerebellar granule
cells (see Tissir and Goffinet, 2003), but very soon came
the demonstration that reelin is preferentially expressed by
GABAergic interneurons in the adult cortex and hippocampus
of rodents (Alcantara et al., 1998; Pesold et al., 1998, 1999).
This was subsequently shown in many other species, including
non-human primates and humans (Martínez-Cerdeño et al.,
2002; Rodriguez et al., 2002; Roberts et al., 2005; Ramos-
Moreno et al., 2006). Although studies with reeler mice already
indicated that reelin played an important role in regulating
neural migration during brain development (see Lambert de
Rouvroit and Goffinet, 1998), additional data demonstrated
key roles for reelin in dendritic maturation and dendritic
spine development (Niu et al., 2008; Chameau et al., 2009), in
promoting synaptic plasticity in spine-impinging synapses, and
in memory formation in the adult brain (Pesold et al., 1999;
Rodriguez et al., 2000; Weeber et al., 2002; Beffert et al., 2005,
2006; Pujadas et al., 2010). More recently, it has become clear that
reelin influences various aspects of hippocampal neurogenesis,
including neural progenitor fate, neuronal migration, dendritic
spine development and the integration of granule neurons
into hippocampal circuitry. The absence of Dab1, a protein
that is part of the reelin signal transduction pathway, limits
dendritic development in dentate neuroprogenitor cells and
causes those cells to migrate ectopically into the hilus (Teixeira
et al., 2012). However, enhancing hippocampal reelin levels
seems to normalize migration and increase the maturation rate
of newborn granule neurons (Pujadas et al., 2010; Teixeira et al.,
2011). Taken together, these results outline an important role for
reelin in regulating hippocampal plasticity in the adult brain.
Although the vast majority of research on reelin has been
conducted in the mammalian brain, reelin is also present
in non-mammalian species. For example, reelin is highly
expressed in the larval sea lamprey brain, particularly during
the metamorphic stage of development (Pérez-Costas et al.,
2002, 2004). Lampreys are primitive vertebrates with a laminar
brain and no conventional radial-migration during development.
Given that reelin is a key regulator of radial-migration in the
rodent brain (Rakic and Caviness, 1995), the presence of reelin
in larval sea lampreys suggests that in phylogenetic terms, reelin
could have initially evolved as a molecule for regulating synaptic
remodeling, and only later on became important for neural
migration (Pérez-Costas et al., 2002).
The conceptualization of reelin as a pleiotropic extracellular
matrix molecule with multiple roles in brain development and
in adult brain plasticity captured the attention of Erminio
Costa and Alessandro Guidotti, who hypothesized that reelin
expression could be dysregulated in psychotic disorders (i.e.,
schizophrenia), and that baseline levels of reelin could be an
important vulnerability factor in a two-hit neurodevelopmental
hypothesis for the development of schizophrenia. Their initial
studies revealed a downregulation of about 50% of brain reelin
expression levels in both schizophrenia and bipolar disorder
(Impagnatiello et al., 1998; Guidotti et al., 2000). These results
were independently replicated by several research groups (Fatemi
et al., 2000; Eastwood and Harrison, 2003; Knable et al., 2004;
Torrey et al., 2005; Habl et al., 2012), opening the field for
subsequent investigation of how reelin dysregulation might be
operative in the pathogenesis and/or pathophysiology of multiple
psychiatric disorders. Years later, Costa and Guidotti pioneered
the study of epigenetic alterations as the possible cause of
reelin downregulation in psychotic disorders (Veldic et al., 2004;
recently reviewed in Grayson and Guidotti, 2013; Guidotti and
Grayson, 2014).
It was Hossein Fatemi who first suggested that reelin may
be downregulated in autism spectrum disorders (Fatemi et al.,
2001b, 2002, 2005; Fatemi, 2002, 2005a,b). This led to the idea of a
co-occurrence of reelin disturbances in autism and schizophrenia
(Fatemi, 2010; Folsom and Fatemi, 2013). In addition, Fatemi’s
group also showed that a downregulation of reelin in the
hippocampus occurred not only in schizophrenia and bipolar
disorder, but also in patients with depression. In this case, they
described a large but non-significant reduction of reelin-positive
cells in the hippocampal CA4 region (the polymorphic region of
the dentate gyrus; Fatemi et al., 2000).
The observation that hippocampal reelin is decreased in
patients with depression led our research group to conduct a
series of experiments to systematically examine whether reelin
is altered in an animal model of depression. Beyond the patient
data described above, it seemed to us that both chronic stress
(an important risk factor for depression) and deficient reelin
produce strikingly similar alterations in hippocampal plasticity
and function. One example if this is the fact that both stress
and deficient reelin can impair adult hippocampal neurogenesis
and the proper maturation and integration of newborn neurons
in the dentate gyrus (Pujadas et al., 2010; Lussier et al., 2013a),
which have been repeatedly implicated in the pathogenesis of
depression (as a recent review, see Schoenfeld and Cameron,
2015). The remainder of this review describes our studies of
reelin-related events in the hippocampus and periphery of
rats using a well characterized animal model of depression
(Kalynchuk et al., 2004; Gregus et al., 2005; Johnson et al.,
2006; Marks et al., 2009; Sterner and Kalynchuk, 2010), as
well as our examination of peripheral biomarkers in depression
patients (Rivera-Baltanás et al., 2012, 2014, 2015). We conclude
by offering some hypotheses about how these ideas could be
explored in a translational way in relation to modifying the reelin
system to develop better diagnoses, prognoses, and therapeutics
for patients with major depression.
REELIN EXPRESSION IN THE
HIPPOCAMPUS: PUTATIVE ROLE IN
DEPRESSION
We first assessed possible deficits in the number of reelin-
immunopositive cells throughout the hippocampus in two
chronic stress paradigms. Many current animal models of
depression are based on chronic or repeated stress paradigms,
because there is a well established relationship between exposure
to traumatic or stressful life events and the onset of depressive
symptoms in patients (Keller et al., 2007). In this case, we used
a repeated corticosterone (CORT) injection paradigm, in which
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rats receive a 40 mg/kg injection of CORT once per day for
21 consecutive days, and a repeated restraint stress paradigm,
in which rats are placed in plastic restraint tubes for 6 h/day
for 21 consecutive days. We chose these two stress paradigms
because we and others had previously found that repeated
CORT injections reliably increase depression-like behavior but
repeated restraint stress does not (Gregus et al., 2005; Brummelte
and Galea, 2010; Workmann et al., 2013; Kott et al., 2016). If
alterations in hippocampal reelin are involved in depression, we
would expect to see a loss of reelin-positive cells in rats subjected
to the CORT injections but not restraint stress. Our results
were consistent with this hypothesis, as we found a significant
decrease (26%) in the number of reelin-positive cells specifically
in the subgranular zone (SGZ) of the dentate gyrus after repeated
CORT injections but not repeated restraint stress (Lussier et al.,
2009). The fact that reelin-positive cells were lost in the SGZ
was notable, as this is the location where adult hippocampal
neurogenesis takes place and from where newborn neurons
migrate into the granular cell layer and develop into mature
granule cells, with dendrites extending through the dentate
molecular layer and axons projecting toward CA3 pyramidal
cells. This suggested to us that stress-induced alterations in
reelin-expressing GABAergic interneurons located adjacent to
the SGZ could influence the course of hippocampal neurogenesis.
To investigate this idea, we compared the time course of changes
in the number of reelin-positive cells in the SGZ, the maturation
rate of newborn granule neurons, and the onset of a depression-
like phenotype in rats subjected to 7, 14, or 21 days of CORT
injections. We found that CORT-treated rats showed gradual
increases in depression-like behavior over the course of the
injections, which were paralleled by significant decreases in SGZ
reelin expression (no changes at 7 days, 25% decrease at 14
days, and 26% decrease at 21 days) and significant decreases
in the number of surviving immature dentate granule cells
and the complexity of dendritic processes present in surviving
immature granule cells (Lussier et al., 2013a). We interpreted
these observations to indicate that reelin downregulation may
delay the maturation of newborn granule cells and impair
proper integration of these neurons into mature circuits, thereby
disrupting hippocampal circuitry and enhancing depression-like
behavior. This conclusion is consistent with other findings that
reeler mice (with null reelin expression) have fewer mitotic cells
in the dentate SGZ than wildtype mice (Sibbe et al., 2015) and
that inactivation of the reelin pathway impairs hippocampal
adult neurogenesis (Teixeira et al., 2012). It also adds a new
component to the prominent hypothesis that adult hippocampal
neurogenesis plays a causal role in major depression (Jacobs
et al., 2000). This hypothesis was derived from data showing
that patients with depression have reduced hippocampal volume
(MacQueen et al., 2003; Campbell et al., 2004) and that chronic
stress and antidepressant drugs can decrease and increase cell
proliferation and survival respectively (Santarelli et al., 2003;
Petrik et al., 2012). However, the putative causal role of
neurogenesis in depression has been controversial because in
animal models, both depression-like behavior and the behavioral
actions of antidepressants can be dissociated from alterations
in hippocampal neurogenesis (Surget et al., 2008; Bessa et al.,
2009; David et al., 2009). Additionally, close examination of
postmortem tissue from depressed patients has not revealed
significant decreases in hippocampal stem cell proliferation
(Lucassen et al., 2001; Reif et al., 2006). Our reelin data point
to the idea that depressive symptoms could be associated with
deficient neuronal maturation and integration rather than cell
proliferation and survival per se. This idea has also been suggested
by other research groups (Bessa et al., 2009; Mateus-Pinheiro
et al., 2013).
Although many studies of reelin in animal models of
depression have focused on the dentate SGZ and adult
hippocampal neurogenesis, this is not the only region of the
hippocampus where reelin is altered after a period of chronic
stress. We have also reported that repeated CORT injections
significantly decrease the number of reelin-positive cells in the
CA1 stratum lacunosum-moleculare (by 21%), and dampen
the co-expression of reelin and neuronal nitric oxide synthase
(nNOS) in the molecular layer of the dentate gyrus (Lussier et al.,
2009; Romay-Tallón et al., 2015). Early descriptions of reelin
immunolabeling in the adult hippocampus identified a heavy
‘‘diffuse labeling’’ in both the distal molecular layer of the dentate
gyrus and the CA1 stratum lacunosum-moleculare (Pesold et al.,
1998), which was interpreted to indicate the presence of reelin
secreted into the extracellular matrix that would regulate the
strength of synaptic connections onto distal dendritic spines
(Pesold et al., 1999; Rodriguez et al., 2000). Later on, it was shown
that reelin signaling regulates glutamate receptor composition
and activity particularly in the distal dendritic compartment
(Chen et al., 2005; Sinagra et al., 2005; Qiu et al., 2006;
Groc et al., 2007; Campo et al., 2009; Iafrati et al., 2014;
Kupferman et al., 2014), and also that reelin could play a role in
neurotransmitter release (Hellwig et al., 2011; Bal et al., 2013).
The downregulation and neurochemical alterations of reelin-
positive cells in the distal molecular layer and CA1 stratum-
lacunosum-moleculare instigated by chronic stress could then
result in changes in synaptic strength and/or glutamatergic
receptors, and/or neurotransmitter release that will further affect
hippocampal circuitry. This fits quite nicely with our report that
repeated CORT injections significantly decrease expression of
GAD65 and the GABAA α2 receptor subunit in the amygdala and
hippocampus and increase expression of VGLUT2 within the
hippocampus (Lussier et al., 2013b). These changes would create
an imbalance in glutamatergic-GABAergic neurotransmission
within the hippocampus, which could be another important
pathophysiologic event in depression that is instigated by a deficit
in reelin.
Heterozygous reeler mice have been used as a way to study the
functional consequences of genetic deficits in reelin expression.
These mice have about 50% of normal levels of reelin in bothe
the brain and peripheral tissues. Previous work with these mice
revealed mild neurochemical (Liu et al., 2001; Pappas et al., 2001;
Ballmaier et al., 2002; Isosaka et al., 2006; Romay-Tallón et al.,
2010; Nullmeier et al., 2011; Ventrutti et al., 2011; Varela et al.,
2015), and behavioral (Tueting et al., 1999, 2006) alterations that
did not appear to give rise to an overt pathological phenotype,
but that could prime these animals to a high vulnerability to
the deleterious effects of chronic stressors. We tested this idea
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by investigating whether heterozygous reeler mice would be
more susceptible to the depressogenic effects of repeated CORT
injections than wildtype mice. Groups of heterozygous reeler
mice and wildtype mice received daily injections of CORT (i.e.,
at 5 mg/kg, 10 mg/kg, or 20 mg/kg) over a 21-day period.
We found that in the absence of CORT, heterozygous reeler
mice do not show more depression-like behavior or deficits in
the number or maturation rate of immature neurons compared
to wildtype mice. However, the heterozygous reeler mice were
more susceptible than wildtype mice to the damaging effects of
CORT, as they showed dose dependent increases in depression-
like behavior and decreases in neuronal survival and maturation
(Lussier et al., 2011). Furthermore, analysis of the colocalization
of reelin and nNOS in CORT-treated heterozygous reeler mice
revealed a genotype × treatment interaction, with increased
colocalization of both markers in the dentate SGZ in CORT
treated heterozygous reeler mice. This indicates that chronic
stress increases nNOS expression in reelin-positive cells when
baseline levels of reelin are relatively low. This increase in
nNOS expression could stimulate the release of nitric oxide,
giving rise to an excitotoxic event through hyperactivation of
NMDA glutamate receptors in these cells. Hypothetically, this
excitotoxicity could have downstream consequences such as a
loss of reelin release from GABAergic interneurons and the
interruption of normal migration and maturation of newborn
dentate granule cells (Romay-Tallón et al., 2015), as discussed
above.
Overall, the evidence gathered to date clearly shows that reelin
is important for adult hippocampal plasticity and that exposure
to chronic stress or high levels of circulating glucocorticoids
dampens reelin activity, with subsequent deficits in neuronal
maturation and the development of depression-like behavior.
Figure 1 shows two possible roles for reelin in the pathogenesis
of depression. It should be pointed out that the experiments
that these ideas were developed from have all been conducted
using male rodents, and there is some evidence that reelin may
be differentially altered in male and female rodents under stress
conditions (van den Buuse et al., 2012; Buret and van den Buuse,
2014). Nevertheless, the data described above beg the question
of whether rescuing or enhancing hippocampal reelin could
have antidepressant effects. We have recently demonstrated that
administration of the tricylic antidepressant imipramine during
the period of CORT injections prevents the downregulation
of hippocampal reelin and rescues the behavioral phenotype
(Fenton et al., 2015a). Other researchers have also shown
that repeated citalopram administration counteracts the loss
of hippocampal reelin after kainic-acid treatment (Jaako et al.,
2011). Although these experiments do not provide definitive
evidence that an enhancement of reelin is directly responsible
for better behavioral outcomes, they are certainly consistent
with that idea. There is a need for future studies to examine
whether reelin enhancement is part of themechanism underlying
the therapeutic effects of antidepressant drugs. Furthermore,
recent evidence has shown that intraventricular reelin infusions
facilitate hippocampal-dependent cognition in a mouse model of
Angelman syndrome (Hethorn et al., 2015). These authors did
not report a specific mechanism by which reelin supplementation
could facilitate memory in these mice. The identification of this
mechanism is an important next step, which could also inform
the development of novel antidepressant drugs or mechanisms
of action for antidepressant drug actions (see discussion below).
PERIPHERAL REELIN IN RELATION
TO PSYCHONEUROIMMUNOLOGY
Soon after the cloning of the reelin gene came the demonstration
that reelin expression is not exclusive to the central nervous
system, but that it is also expressed in other body regions both
during developmental stages and adulthood. These regions were
primarily identified as the yolk sac and blood vessels during
developmental stages, and throughout life in the kidney, liver,
and blood (Ikeda and Terashima, 1997; Smalheiser et al., 2000).
Since then, reelin expression has also been shown in lymphatic
tissues (Samama and Boehm, 2005; Lutter et al., 2012), platelets
(Tseng et al., 2010), the enteric nervous system (Bottner et al.,
2014), bone marrow (Chu et al., 2014), and some adult brain
endothelial cells (Pérez-Costas et al., 2015). Although many
studies have focused on the functional roles of reelin in brain
development and the adult nervous system, there is scarce
knowledge about the functional role reelin might play in the
periphery. The picture so far illustrates reelin as a pleiotropic
molecule with diverse functional roles both in the brain and
periphery: as such, reelin is known to be released from liver
and/or kidney cells into blood plasma (Smalheiser et al., 2000),
where it plays a role in regulating erythropoiesis in the bone
marrow (Chu et al., 2014), and in hemostasis (Tseng et al., 2010,
2014). Reelin also regulates lymphatic vessel formation (Lutter
et al., 2012); and the remodeling of the vascular network in
reelin-deficient mice (Lindhorst et al., 2012) together with the
expression of reelin in yolk sac and developing blood vessels
(Ikeda and Terashima, 1997), has led to the idea that reelin may
be involved in blood vessel formation.
After our studies indicating that the addition of recombinant
reelin to synaptosomes can increase protein expression (Dong
et al., 2003), and that this increase was also accompanied
by an augmentation of protein clustering on synaptosomal
membranes (Caruncho et al., 2004), we wondered whether
reelin could regulate membrane protein clustering along the cell
membrane of peripheral blood cells (i.e., lymphocytes). Several
observations informed this question, including the fact that reelin
is highly expressed in blood plasma (Smalheiser et al., 2000),
that plasma reelin is altered in mood and psychotic disorders
(Fatemi et al., 2001a), that reelin induces clustering of its own
receptors receptors and this is an important event for signaling
(Strasser et al., 2004), and that lymphocytes contain reelin
receptors whose expression is changed in psychiatric disorders
(Suzuki et al., 2008). We hypothesized that a decrease in reelin
levels or null reelin expression, as observed in heterozygous or
homozygous reeler mice respectively, would alter the clustering
of some specific proteins, such as the serotonin transporter,
that tend to bunch into lipid rafts. We subsequently observed
important alterations in the number and size of serotonin
transporter clusters in both hererozygous and homozygous reeler
mice, particularly in the latter where most lymphocytes showed
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FIGURE 1 | Graphical depiction of two possible mechanisms by which reelin down-regulation may be involved in the pathophysiology of depression.
(A) Reelin secreted by some hippocampal GABAergic interneurons in the dentate subgranular zone (SGZ) as well as in cells in the distal molecular layer (shown in
red) is involved in hippocampal neurogenesis, particularly the rate and extent of dendritogenesis of newborn granule cells (shown in blue). Repeated CORT
administration reduces the number of reelin+ cells in the dentate SGZ and the amount of extracellular reelin in the distal molecular layer, which delays the maturation
(e.g., reduced dendritogenesis) of newborn neurons. These neurons may fail to properly integrate into existing hippocampal circuits. (B) Reelin secreted by
GABAergic interneurons promotes and stabilizes synapses impinging onto dendritic spines. The downregulation and neurochemical alterations of reelin-positive cells
in the distal molecular layer and CA1 stratum-lacunosum-moleculare (shown in red) instigated by chronic stress would decrease in the number of dendritic spines,
resulting in a loss of glutamatergic synaptic strength and possibly a dampening of neurotransmitter release from glutamatergic terminals (shown in blue). This would
further affect hippocampal circuitry.
a diffuse serotonin transporter immunostaining that made it
difficult to identify individual clusters (Rivera-Baltanás et al.,
2010). Not surprisingly, heterozygous and homozygous reeler
mice have dysregulated secretion of cytokines by lymphocytes
and macrophages (Green-Johnson et al., 1995).
It is now commonplace to conceptualize inflammatory events
as key components in the pathophysiology of depression (see as
reviews Raison et al., 2006; Maes et al., 2009; Miller et al., 2009;
Leonard, 2010; Blume et al., 2011; Sperner-Unterweger et al.,
2014; Young et al., 2014). In fact, levels of inflammatory cytokines
are one of the best characterized biomarkers of depression (see
as reviews Mössner et al., 2007; Howren et al., 2009; Li et al.,
2011; Lichtblau et al., 2013; Valkanova et al., 2013). Taking into
account the just mentioned alterations in immune cells in mice
expressing low levels of reelin, as well as the disturbances in reelin
immunoreactive cells in the dentate gyrus of both depressive
patients (Fatemi et al., 2000) and rats showing depression-like
behavior (Lussier et al., 2013a), we examined the pattern of
lymphocyte membrane protein clustering in peripheral blood
samples taken from rats treated with repeated CORT injections
(i.e., showing a depressive-like phenotype) and from patients
with depression both before treatment and after 8 weeks of
antidepressant drug treatment. The pattern of protein clustering
of the serotonin transporter and the serotonin 2A receptor
on the cell membrane of lymphocytes from rats treated for
3 weeks with CORT showed a significant increase in cluster
size for both markers in comparison with control rats, and
also a significant positive correlation between larger membrane
protein clusters and more depression-like behavior in the forced-
swim test (Fenton et al., 2015b). Studies of lymphocytes from
depression patients revealed an increase in the size of both
serotonin transporter and serotonin 2A receptor protein clusters
along the plasma membrane, similar to the alterations found
in the CORT-treated rats. However, an important difference is
that the analysis of the pattern of clustering of these markers
also allowed us to differentiate two subpopulations of naïve
depression patients that showed different therapeutic outcomes
after antidepressant treatment (i.e., a subpopulation of naïve
depression patients that had a poor response to treatment
showed smaller clusters and a high percentage of clusters of
0.05–0.10 µm2, whereas a subpopulation of naïve patients with
better therapeutic outcomes showed larger clusters and a small
percentage of clusters of 0.05–0.10 µm2). These observations led
us to propose that analyses of membrane protein clustering may
be a new approach to identify novel biomarkers of depression,
and perhaps of other psychiatric disorders as well (Rivera-
Baltanás et al., 2012, 2014). Recently, we demonstrated that
alterations in serotonin transporter clustering in lymphocytes
in depression also correlate with remittance of anhedonia
symptoms after antidepressant treatment (Rivera-Baltanás et al.,
2015). This finding is of great interest when considering
that anhedonia not only represents a cardinal symptom of
depression, but it also is generally considered a symptom that
shows a relatively poor response to conventional antidepressant
treatment (Spijker et al., 2001; Pizzagalli, 2014). Therefore, being
able to identify naïve depression patients that will show good or
poor improvement in anhedonia symptoms may be useful in a
clinical setting.
We are currently evaluating if different subpopulations of
lymphocytes are differentially affected in terms of membrane
protein clustering in depression, and also how these alterations
may give rise to changes in the release of cytokines, which is
of special interest for us when considering the depressogenic
effects of cytokines in anhedonia (Anisman et al., 2002).
The hypothesis driving this work is that alterations in reelin
expression and membrane protein clustering in peripheral
lymphocytes and monocytes may underlie some of the
dysregulation in expression of pro-inflammatory and/or anti-
inflammatory cytokines that may play a key role in the
pathophysiology of major depression. Figure 2 depicts a possible
mechanism of how reelin dysregulation may relate to these
events.
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FIGURE 2 | Schematic representation of alterations in membrane
protein clustering in depression. One of the roles of peripheral reelin may
be to regulate membrane protein clustering in lymphocytes (see text for
details). If peripheral reelin is decreased in depression, the pattern of protein
clustering in peripheral immune cells could be altered. The figure shows our
findings that patients with depression have generally larger protein clusters
(shown in green) along the lymphocyte plasma membrane than
non-depressed subjects (see Rivera-Baltanás et al., 2012, 2014). We propose
that alterations in protein clustering in depression patients could stimulate
cytokine secretion, as has been frequently reported in depression.
In relation to reelin expression in plasma and membrane
protein clustering in depression, it is also of interest to consider
that alterations in the pattern of clustering appear to affect
proteins that tend to integrate within lipid rafts, such as the
serotonin transporter (Magnani et al., 2004), and that shifting of
Gα-proteins to and from lipid raft domains has been postulated
as a possible mechanism involved in the chronic effects of
antidepressants (Zhang and Rasenick, 2010; Czysz et al., 2015).
This opens the possibility of studying combined alterations
in membrane protein clustering and Gα-protein translocation
to/from lipid rafts as an additional operative mechanism in the
pathophysiology of depression that may be amenable to novel
therapeutic intervention.
THE REELIN SYSTEM AS A TARGET FOR
NOVEL ANTIDEPRESSANTS
The idea that reelin could be a part of the mechanism of
antidepressant drug action or that it could have beneficial
effects on its own was introduced in an earlier section of
this review. This idea appears to be gaining momentum in
the field: Several investigators have used exogenous reelin
(or alternatively, rodent models of reelin overexpression)
to investigate if high reelin levels can revert some of
the neurochemical, anatomical, functional, and behavioral
alterations in various animal models of human pathology.
These studies have revealed that reelin supplementation can
enhance synaptic plasticity, dendritic spine density, and cognitive
ability in wild-type mice (Rogers et al., 2011), and that
it can recover synaptic plasticity and learning deficits in
heterozygous reeler mice (Rogers et al., 2013). The addition
of exogenous reelin also prevents hippocampal dentate granule
cell dispersion in experimental epilepsy (Müller et al., 2009),
has a preventive effect on phencyclidine-induced behavioral
deficits (Ishii et al., 2015), and recovers the neurochemical
and behavioral phenotype in a mouse model for Angelman
syndrome (Hethorn et al., 2015). Overexpression of reelin
also prevents the development of behavioral alterations related
to schizophrenia and bipolar disorder (Teixeira et al., 2011),
and delays amyloid-beta fibril formation and rescues cognitive
deficits in an animal model of Alzheimer’s disease (Pujadas
et al., 2014). Overall, these studies paint a tantalizing picture
of the possible benefits reelin could have for a number of
brain pathologies centered on hippocampal dysfunction. This
is of course, also true for the case of major depression.
The neurochemical and behavioral deficits associated with a
loss of reelin in animal models of depression, together with the
rescuing of behavioral phenotypes by addition or overexpression
of reelin in models of several neuropsychiatric disorders,
strongly suggest that tackling the reelin system (i.e., by the
addition of recombinant reelin, by activating the reelin receptors
VLDLR and/or ApoER2, or by neuroprotection of reelin-positive
cells) could be a good strategy for the development of novel
antidepressants.
The studies mentioned above have all used infusions of
reelin into the brain. Reelin is a very large protein, and it has
been unclear whether peripheral administration of reelin could
influence functions within the brain. However, the recent finding
of reelin immunoreativity product within caveolar vesicles in
endothelial cells in brain regions showing a high level of
extracellular reelin labeling suggests that reelin peptides might
indeed cross the blood-brain-barrier (Pérez-Costas et al., 2015).
This opens the possibility that peripherally administered reelin
could influence brain function. It also suggests that alterations in
reelin could be important in relation to vascular and/or brain-
blood-barrier disturbances in major depression, as these factors
appear to be operative in the pathophysiology of depression
(Najjar et al., 2013; Taylor et al., 2013).
The pattern of alterations in membrane protein clustering
in lymphocytes, together with the multiple observations of
disturbances in proinflammatory cytokines in major depression,
as discussed in the previous section of this report, also raises
the possibility of developing novel therapeutic strategies based
on interventions that act peripherally in the immune system. In
fact, an interesting recent report has shown that lymphocytes
from chronically-stressed mice confer antidepressant-like effects
when transferred to naïve mice (Brachman et al., 2015). In
translating this remarkable observation to the human condition,
one could imagine the possibility of extracting peripheral
lymphocytes from patients with treatment-resistant depression
and developing conditions to treat them in vitro (i.e., conditions
that could result in alterations in membrane protein clustering
that we have found to relate to a good therapeutic outcome)
before re-implanting them in the patients, with the hope that
there would be an effective antidepressant outcome from this
intervention.
In conclusion, the alterations in reelin expression in both
the CNS and periphery in depression (and in animal models
of depression), the analysis of the functional roles of reelin
(and dysfunctions in depression), and the observation of how
reelin can rescue behavioral phenotypes in different paradigms,
strongly suggest that systematically tackling the reelin system
may be a good strategy for developing novel antidepressants.
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However, additional studies at multiple levels will be necessary
to further this field and translate it to the clinic.
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